4 clinical trials found.
-
A Phase 2 Randomized Double-Blind Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease
The purpose of this research study is to measure how effective and how safe BMS-986165 is in treating study participants with moderate to severe Crohn's ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis
The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease
The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
Combined Phase 3 Double-blind Randomized Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
